Alnylam Pharmaceuticals Inc
(HAM:DUL)
€
202.6
+2.3 (+1.15%)
Market Cap: 27.04 Bil
Enterprise Value: 25.30 Bil
PE Ratio: 43.91
PB Ratio: 23.33
GF Score: 70/100 Sorry the transcript is not found. Please try another one.